Cite
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study.
MLA
Ichinose, Kunihiro, et al. “Evaluating the Safety Profile of Calcineurin Inhibitors: Cancer Risk in Patients with Systemic Lupus Erythematosus from the LUNA Registry—a Historical Cohort Study.” Arthritis Research & Therapy, vol. 26, Feb. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13075-024-03285-x.
APA
Ichinose, K., Sato, S., Igawa, T., Okamoto, M., Takatani, A., Endo, Y., Tsuji, S., Shimizu, T., Sumiyoshi, R., Koga, T., Kawashiri, S., Iwamoto, N., Tamai, M., Nakamura, H., Origuchi, T., Yajima, N., Sada, K.-E., Miyawaki, Y., Yoshimi, R., & Shimojima, Y. (2024). Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study. Arthritis Research & Therapy, 26, 1–7. https://doi.org/10.1186/s13075-024-03285-x
Chicago
Ichinose, Kunihiro, Shuntaro Sato, Takashi Igawa, Momoko Okamoto, Ayuko Takatani, Yushiro Endo, Sosuke Tsuji, et al. 2024. “Evaluating the Safety Profile of Calcineurin Inhibitors: Cancer Risk in Patients with Systemic Lupus Erythematosus from the LUNA Registry—a Historical Cohort Study.” Arthritis Research & Therapy 26 (February): 1–7. doi:10.1186/s13075-024-03285-x.